With 35+ tumors (solid and hematopoietic) and 80+ countries, one can query any combination of factors customized for your business area. Each country specific data set has been rigorously analyzed to create an accurate view of the epidemiology of specific cancer types. The database is fully documented with the sources and assumptions used to support the global numbers.
User Friendly and Interactive
PRECISE displays a visualization map of cancers by anatomical sites.
Each tumor can be customized so that key considerations and patient segments are included for the tumor:
- Relevant stages/grades
- Tumor specific treatments
- Important tumor markers
- Advanced stage lines of therapy
GLOBAL COVERAGE
Registry data for 80+ countries used to create country specific cancer epidemiology
| Algeria | Croatia | Hungary | Malta | Russia | United Kingdom |
| Argentina | Cyprus | India | Mauritania | Saudi Arabia | United States |
| Armenia | Czech Republic | Indonesia | Mexico | Serbia | Uruguay |
| Australia | Denmark | Iran | Morocco | Singapore | Uzbekistan |
| Austria | Dominican Republic | Ireland | Netherlands | Slovakia | Venezuela |
| Bahrain | Ecuador | Israel | New Zealand | Slovenia | |
| Belarus | Egypt | Italy | Nicaragua | South Africa | |
| Belgium | El Salvador | Japan | Norway | South Korea | |
| Bolivia | Estonia | Jordan | Oman | Spain | |
| Bosnia | Finland | Kazakhstan | Pakistan | Sweden | |
| Brazil | France | Kuwait | Panama | Switzerland | |
| Bulgaria | Germany | Latvia | Peru | Taiwan | |
| Canada | Greece | Lebanon | Philippines | Thailand | |
| Chile | Guatemala | Libya | Poland | Tunisia | |
| China | Herzegovina | Lithuania | Portugal | Turkey | |
| Columbia | Honduras | Luxemburg | Qatar | Ukraine | |
| Costa Rica | Hong Kong | Malaysia | Romania | United Arab Emirates |
Fully Documented
Sources and assumptions used to create the data
Customized Treatment Data
Users can customize treatment data depending on the source of information. Easily integrate user specific data purchased on the secondary market; or Tessellon can conduct primary market research to help customize the treatment data
User-Defined Indications
Users can create their own specific indications aligning with clinical trials or product label to visualize the size of the market by each indication
Flexible Access
Pay for complete or partial access based on your needs. Unlimited yearly database access - maintenance fees required with no forced renewal, upgrade when you are ready!